Titre : | The potential impact of timing of IVIG administration on the efficacy of rituximab for immune tolerance induction for patients with Pompe disease |
Revue : | Clinical immunology (Orlando, Fla.), 219 |
Auteurs : | Desai AK ; Rosenberg AS ; Kishnani PS |
Type de document : | Article |
Editeur : | United States, 2020 |
Langues: | Anglais |
Mots-clés: | anti-drug antibodies;anti-rhGAA IgG antibodies;enzyme replacement therapy;immunomodulation;Pompe disease; |
Pubmed / DOI : | Pubmed : 32681978 / DOI : 10.1016/j.clim.2020.108541 |
N° Profil MNM : | 2020071 |
En ligne : | http://www.ncbi.nlm.nih.gov/pubmed/32681978 |